Earthgenes Pharmaceuticals' Grant - II Round

Earthgenes Pharmaceuticals raised a round of funding on July 13, 2007. Investors include National Science Foundation.

Earthgenes Pharmaceuticals is a company that received a STTR Phase II grant for a project entitled: An Advanced Antibiotic Screen of Marine Environmental DNA through a Metabolically Engineered E. coli…

Articles about Earthgenes Pharmaceuticals' Grant - II Round: